Coprosterol

Coprosterol is a lipid of Sterol Lipids (ST) class. Coprosterol is associated with abnormalities such as Cerebrovascular accident, Glycogen Storage Disease Type IV, Coronary Arteriosclerosis, CARDIAC EVENT and Diabetes Mellitus, Non-Insulin-Dependent. The involved functions are known as cholesterol absorption, Death, Sudden, Cardiac, Drug Interactions, Cholesterol Homeostasis and Synthesis. Coprosterol often locates in lipid raft, Tissue membrane, Membrane, Blood and Body tissue. The associated genes with Coprosterol are ABO gene, STN gene, Alleles, Apolipoprotein E gene and TNF gene. The related lipids are saturated fat, campesterol, lathosterol, Sterols and Total cholesterol. The related experimental models are Rodent Model.

Cross Reference

Introduction

To understand associated biological information of Coprosterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Coprosterol?

Coprosterol is suspected in Coronary Arteriosclerosis, Cerebrovascular accident, Glycogen Storage Disease Type IV, CARDIAC EVENT, Diabetes Mellitus, Non-Insulin-Dependent, Niemann-Pick Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Coprosterol

MeSH term MeSH ID Detail
Hypercholesterolemia D006937 91 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Cataract D002386 34 associated lipids
Alcoholism D000437 27 associated lipids
Xanthomatosis D014973 17 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Biliary Fistula D001658 13 associated lipids
Brain Diseases, Metabolic D001928 9 associated lipids
Total 9

PubChem Associated disorders and diseases

What pathways are associated with Coprosterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Coprosterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Coprosterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Coprosterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Coprosterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Coprosterol?

Rodent Model

Rodent Model are used in the study 'Formation of 7-dehydrocholesterol-containing membrane rafts in vitro and in vivo, with relevance to the Smith-Lemli-Opitz syndrome.' (Keller RK et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Coprosterol

Download all related citations
Per page 10 20 50 100 | Total 485
Authors Title Published Journal PubMed Link
Férézou J et al. Daily elimination of fecal neutral sterols by humans. 1978 Digestion pmid:367852
Lee SP Enhanced fluid transport across gallbladder mucosa in experimental cholelithiasis. 1978 Am. J. Physiol. pmid:352156
Huang CT et al. Fecal steroids in diarrhea. II. Travellers' diarrhea. 1978 Am. J. Clin. Nutr. pmid:345794
Sulpice JC et al. Diet and sterol biohydrogenation in the rat: occurrence of epicoprostanol. 1978 Lipids pmid:345032
Sadzikowski MR et al. Cholesterol-reducing bacterium from human feces. 1977 Appl. Environ. Microbiol. pmid:335969
Nigro ND et al. A comparison of the effects of the hypocholesteremic agents, cholestyramine and candicidin, on the induction of intestinal tumors in rats by azoxymethane. 1977 Cancer Res. pmid:328141
Reddy BS et al. Fecal bile acids and cholesterol metabolites of patients with ulcerative colitis, a high-risk group for development of colon cancer. 1977 Cancer Res. pmid:322859
Gustafsson BE and Norin KE Development of germfree animal characteristics in conventional rats in antibiotics. 1977 Acta Pathol Microbiol Scand B pmid:320818
Kay RM and Truswell AS Effect of citrus pectin on blood lipids and fecal steroid excretion in man. 1977 Am. J. Clin. Nutr. pmid:319647
Elliott CG and Sansome E The influence of sterols on meiosis in Phytophthora cactorum. 1977 J. Gen. Microbiol. pmid:319196
Shefer S et al. Competitive inhibition of bile acid synthesis by endogenous cholestanol and sitosterol in sitosterolemia with xanthomatosis. Effect on cholesterol 7 alpha-hydroxylase. 1988 J. Clin. Invest. pmid:3143743
Midtvedt AC et al. Development of five metabolic activities associated with the intestinal microflora of healthy infants. 1988 Jul-Aug J. Pediatr. Gastroenterol. Nutr. pmid:3135382
Koivisto PV and Miettinen TA Plasma and biliary cholestanol related to steroid metabolism in familial hypercholesterolemia patients with and without ileal exclusion. 1988 Clin. Chim. Acta pmid:3133140
Hirsch D et al. DSC, X-ray and NMR properties of cholesterol-cholestanol-dihydrate crystals. 1988 Clin. Chim. Acta pmid:3133139
Garraffo HM and Gros EG Biosynthesis of bufadienolides in toads. VI. Experiments with [1,2-3H]cholesterol, [21-14C]coprostanol, and 5 beta-[21-14 C]pregnanolone in the toad Bufo arenarum. 1986 Sep-Oct Steroids pmid:3127947
Midtvedt T et al. Establishment of a biochemically active intestinal ecosystem in ex-germfree rats. 1987 Appl. Environ. Microbiol. pmid:3124742
van Faassen A et al. Bile acids, neutral steroids, and bacteria in feces as affected by a mixed, a lacto-ovovegetarian, and a vegan diet. 1987 Am. J. Clin. Nutr. pmid:3120571
Peuchant E et al. Relationship between fecal neutral steroid concentrations and malignancy in colon cells. 1987 Cancer pmid:3111679
Salen G et al. Increased concentrations of cholestanol and apolipoprotein B in the cerebrospinal fluid of patients with cerebrotendinous xanthomatosis. Effect of chenodeoxycholic acid. 1987 N. Engl. J. Med. pmid:3106810
Lozano R et al. Metabolism of sterols of varying ring unsaturation and methylation by Caenorhabditis elegans. 1987 Lipids pmid:3104715
Seidel SB et al. Minor and trace sterols from marine invertebrates 56. Novel coprostanols from the marine sponge Petrosia ficiformis. 1986 Steroids pmid:3101232
Parker F Normocholesterolemic xanthomatosis. 1986 Arch Dermatol pmid:3096220
Bhattacharyya AK Differences in uptake and esterification of saturated analogues of cholesterol by rat small intestine. 1986 Am. J. Physiol. pmid:3094380
Clifford AJ et al. Effects of dietary triglycerides on serum and liver lipids and sterol excretion of rats. 1986 J. Nutr. pmid:3088226
Kasama T and Seyama Y Biochemical diagnosis of cerebrotendinous xanthomatosis using reversed phase thin layer chromatography. 1986 J. Biochem. pmid:3086296
Midtvedt T et al. Influence of peroral antibiotics upon the biotransformatory activity of the intestinal microflora in healthy subjects. 1986 Eur. J. Clin. Invest. pmid:3084266
Hayashi E et al. Fecal bile acids and neutral sterols in rats with spontaneous colon cancer. 1986 Int. J. Cancer pmid:3082773
Miettinen TA et al. Cholesterol precursor sterols, plant sterols, and cholestanol in human bile and gallstones. 1986 Gastroenterology pmid:3081398
Katz DA et al. Peripheral neuropathy in cerebrotendinous xanthomatosis. 1985 Arch. Neurol. pmid:2994606
Cabral AC et al. An integrated evaluation of some faecal indicator bacteria (FIB) and chemical markers as potential tools for monitoring sewage contamination in subtropical estuaries. 2018 Environ. Pollut. pmid:29339343
Tibrewal S et al. Cerebrotendinous xanthomatosis: early diagnosis on the basis of juvenile cataracts. 2017 J AAPOS pmid:29079218
Lamiquiz-Moneo I et al. ABCG5/G8 gene is associated with hypercholesterolemias without mutation in candidate genes and noncholesterol sterols. J Clin Lipidol pmid:29066094
Othman RA et al. Thyroid Hormone Status in Sitosterolemia Is Modified by Ezetimibe. 2017 J. Pediatr. pmid:28625503
Chen C et al. Clinical and molecular genetic features of cerebrotendinous xanthomatosis patients in Chinese families. 2017 Metab Brain Dis pmid:28623566
Alhariri A et al. Clinical report: A patient with a late diagnosis of cerebrotendinous xanthomatosis and a response to treatment. 2017 Am. J. Med. Genet. A pmid:28590052
Vahouny GV et al. Dietary fiber supplementation and fecal bile acids, neutral steroids and divalent cations in rats. 1987 J. Nutr. pmid:2826726
Mast N et al. Cytochrome P450 27A1 Deficiency and Regional Differences in Brain Sterol Metabolism Cause Preferential Cholestanol Accumulation in the Cerebellum. 2017 J. Biol. Chem. pmid:28190002
Reis SA et al. Mechanisms responsible for the hypocholesterolaemic effect of regular consumption of probiotics. 2017 Nutr Res Rev pmid:27995830
Koyama S and Kato T Pathophysiology of cerebrotendinous xanthomatosis. 2016 Rinsho Shinkeigaku pmid:27840382
Koge J et al. A case of cerebrotendinous xanthomatosis mimicking the clinical phenotype of mitochondrial disease with a novel frame-shift mutation (c. 43_44 delGG) in CYP27A1 gene exon 1. 2016 Rinsho Shinkeigaku pmid:27680221
Mattis CE and Mootoo DR A ring closing metathesis strategy for carbapyranosides of xylose and arabinose. 2016 Carbohydr. Res. pmid:27236269
Frena M et al. Evaluation of anthropogenic contamination using sterol markers in a tropical estuarine system of northeast Brazil. 2016 Mar. Pollut. Bull. pmid:27207024
Matić Bujagić I et al. Sterol ratios as a tool for sewage pollution assessment of river sediments in Serbia. 2016 Environ. Pollut. pmid:26874877
Antharam VC et al. An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection. 2016 PLoS ONE pmid:26871580
Whiteside W et al. Altered Cholesterol Metabolism and Hypocholesterolemia in Patients with Single Ventricle following Fontan Palliation. 2016 J. Pediatr. pmid:26806364
Rada JPA et al. Sewage contamination of sediments from two Portuguese Atlantic coastal systems, revealed by fecal sterols. 2016 Mar. Pollut. Bull. pmid:26778497
Dayspring TD et al. Biomarkers of cholesterol homeostasis in a clinical laboratory database sample comprising 667,718 patients. 2015 Nov-Dec J Clin Lipidol pmid:26687702
Appadurai V et al. Apparent underdiagnosis of Cerebrotendinous Xanthomatosis revealed by analysis of ~60,000 human exomes. 2015 Mol. Genet. Metab. pmid:26643207
Andrade I et al. Cholesterol absorption and synthesis markers in Portuguese hypercholesterolemic adults: A cross-sectional study. 2016 Eur. J. Intern. Med. pmid:26577223
Devane ML et al. Identifying avian sources of faecal contamination using sterol analysis. 2015 Environ Monit Assess pmid:26370196